Health Sciences Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HESG research report →
Companywww.healthsciencesgroup.com
Health Sciences Group Inc. , through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. It primarily offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; and Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for the maintenance of cardiovascular health and a free-flowing circulatory system.
- CEO
- Thomas Gaffney
- IPO
- 2001
- Employees
- 2
- HQ
- Newport Beach, CA, US
Price Chart
Valuation
- Market Cap
- $1.87M
- P/E
- -0.00
- P/S
- 5.22
- P/B
- 0.00
- EV/EBITDA
- -48.96
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 7.04%
- Op Margin
- -15.20%
- Net Margin
- -15.20%
- ROE
- 2.53%
- ROIC
- -5.95%
Growth & Income
- Revenue
- $358.43K · 0.00%
- Net Income
- $-54,487 · 0.00%
- EPS
- $-0.03 · 0.00%
- Op Income
- $-54,487
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.33
- Avg Volume
- 1.68K
Get TickerSpark's AI analysis on HESG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HESG Coverage
We haven't published any research on HESG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HESG Report →